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G protein-coupled receptors (GPCRs) comprise the
largest family of transmembrane signaling molecules
and regulate a host of physiological and disease pro-
cesses. To better understand the functions of GPCRs
in vivo, we quantified transcript levels of 353 nono-
dorant GPCRs in 41 adult mouse tissues. Cluster
analysis placed many GPCRs into anticipated ana-
tomical and functional groups and predicted previ-
ously unidentified roles for less-studied receptors.
From one such prediction, we showed that the
Gpr91 ligand succinate can regulate lipolysis in white
adipose tissue, suggesting that signaling by this citric
acid cycle intermediate may regulate energy homeo-
stasis. We also showed that pairwise analysis of
GPCR expression across tissues may help predict
drug side effects. This resource will aid studies to un-
derstand GPCR function in vivo and may assist in the
identification of therapeutic targets.
INTRODUCTION
Mammalian cells sense myriad signals in their environment via
G protein-coupled receptors (GPCRs), the largest family of trans-
membrane signaling molecules. GPCRs can be partitioned into
two groups: odorant/sensory and nonodorant. Odorant/sensory
receptors are restricted to specialized cells that detect external
cues—odors, tastes, and pheromones—and regulate organis-
mal behaviors such as feeding and mating. Nonodorant GPCRs
are differentially expressed throughout the organism, respond
to diverse endogenous ligands, and regulate a host of physiolog-
ical processes including hematopoiesis, hemostasis, immune
function, metabolism, neurotransmission, reproduction, cardiac
function, and vascular tone. Accordingly, such receptors are
the targets for about one-third of all approved drugs (Hopkins
and Groom, 2002; Muller, 2000). Although in vivo roles have
been defined for many of the approximately 370 nonodorant
GPCRs in mice and humans, the expression and function of
many such receptors are incompletely characterized, and a
significant fraction remain orphans (Fredriksson et al., 2003; Fre-
driksson and Schioth, 2005; Hill et al., 2002; Joost and Methner,
2002; Vassilatis et al., 2003).To support studies of nonodorant GPCR function, we ana-
lyzed the pattern of GPCR mRNA expression across tissues
and the relative abundance for each of 353 nonodorant GPCRs
in 41 tissues from adult mice. Hierarchical clustering analysis re-
vealed groupings of tissues and receptors that predicted physi-
ological functions for individual receptors and receptor clusters.
We tested one such prediction by examining Gpr91, a receptor
for the citric acid cycle intermediate succinate (He et al., 2004).
Gpr91 was grouped in the ‘‘adipose cluster,’’ but neither Gpr91
nor succinate was known to regulate adipocyte functions. We
demonstrated that extracellular succinate can inhibit lipolysis
in white adipose tissue in a manner consistent with its acting
via adipocyte Gpr91. Overall, this data set provides a resource
for those interested in finding previously unidentified roles for
GPCRs with known ligands and hints regarding the functions
of orphan GPCRs and the sources of their ligands. When com-
pared with human expression data (SymAtlas, SAGEmap), these
mouse data will aid the rational use of mice to model GPCR func-
tion in human physiology and disease and may help point up new
therapeutic targets and predict on-target side effects. In addi-
tion, these quantitative data describing expression of a large
number of related and relatively small genes across many tissues
may support studies aimed at identifying cis-acting elements
and transcription factors that dictate expression in particular
tissues.
RESULTS
Tissue Profiling of GPCRs by qPCR
GPCRs are usually expressed at low levels. Indeed, nonodorant
GPCRs comprise about 1% of genes in the genome, but only
0.001%–0.01% of expressed sequence tags (ESTs) correspond
to GPCRs (Fredriksson and Schioth, 2005). Accordingly, we
chose TaqMan-type quantitative real-time polymerase chain
reaction (qPCR) for its high sensitivity, specificity, and broad dy-
namic range to measure GPCR mRNA expression. Primer/probe
sets were validated as described in the Experimental Proce-
dures; their sequences are provided in Table S3 available online.
Transcript levels for 353 GPCRs were profiled in 41 adult
tissues isolated from C57BL/6 mice. Bar graphs indicating tran-
script levels for each receptor in each tissue relative to internal
controls (b-actin, cyclophilin, GAPDH, and ribosomal protein
S9) are found in the Supplemental Data Set and at http://pdsp.
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Table 1. GPCRs Ubiquitously and Abundantly Expressed In Vivo
Tissue GPCRs
Ubiquitous Cd97, Ebi2, Edg1(S1p1), Edg3(S1p3), Ednra, Etl(Eltd1), F2r(Par1), Fzd1, Fzd7, Gabbr1, Gpr10(Prlhr), Gpr105(P2ry14), Gpr107,
Gpr108, Gpr19, Gpr56, Il8rb(Cxcr2), Lec1(Lphn2), Lec2(Lphn1), P2y5, Ptger1(Ep1), Tm7sf1(Gpr137b), Tm7sf1l1(Gpr137),
Tm7sf3, Tpra40(Gpr175)
CNS Adcyap1r1, Adora1, Bai1, Bai2, Celsr2, Chrm1, Cnr1, Drd1, Drd4, Edg1(S1p1), Ednrb, Fy(Darc), Fzd1, Fzd3, Gabbr1, Glp2r,
Gpr108, Gpr22, Gpr26, Gpr37(Paelr), Gpr37l1, Gpr49(Lgr5), Gpr51(Gabbr2), Gpr56, Gprc5b(Raig2), Grca(Gpr162),
Grm1(Mglur1), Grm3(Mglur3), Grm4(Mglur4), Grm5(Mglur5), Grm6(Mglur6), Grm7(Mglur7), Hrh3, Il8rb(Cxcr2), Kiaa1828(Gpr123),
Lec2(Lphn1), Lec3(Lphn3), Ntsr2, Opn1mw, Opn1sw, Oprl1, Pgr15(Gpr165), Pgr22(Gpr155), Rgr, Rho, Tm7sf1l1(Gpr137)
Endocrine Adora1, Agtr1(Agtr1a), Casr, Drd2, F2r(Par1), Ghrhr, Glp1r, Gpr108, Gpr48(Lgr4), Gpr56, Lec2(Lphn1), Rai3(Gprc5a),
Rdc1(Cxcr7), Tm7sf1(Gpr137b), Tm7sf1l1(Gpr137)
Cardiovascular Agtr1(Agtr1a), Chrm2, Edg1(S1p1), Ednra, Etl(Eltd1), F2r(Par1), Fzd1, Fzd2, Fzd4, Kiaa0758(Gpr116), Rdc1(Cxcr7)
Metabolic Adrb3, Agtr1(Agtr1a), Cmkbr1l1(Ccr1l1), Edg1(S1p1), Etl(Eltd1), Fzd4, Gcgr, Gpr10(Prlhr), Gpr48(Lgr4), Gpr56, Gpr91(Sucnr1),
Hm74(Gpr109a), Ptger3(Ep3), Pthr1, Tm7sf1(Gpr137b)
Gastroenteric Cckar, Flj14454(Gpr128), Fzd1, Glp1r, Gpr108, Ptger3(Ep3), Rai3(Gprc5a)
Immune Adrb2, Ccr9, Cxcr4, Edg1(S1p1), Fpr-rs2, Gpr18, Il8rb(Cxcr2), Mrga3, P2y5
Reproductive Agtr1(Agtr1a), Gpcr150, Gpr108, Gpr19, Tm7sf1l1(Gpr137)
Pulmonary Adrb2, Calcrl, Cckar, Cd97, Edg1(S1p1), Edg3(S1p3), Etl(Eltd1), F2r(Par1), Glp1r, Gpr108, Gpr56, Kiaa0758(Gpr116),
Rai3(Gprc5a), Tm7sf1(Gpr137b), Tm7sf1l1(Gpr137)
Barrier Hm74(Gpr109a)GPCR expression levels varied dramatically by tissue. Predict-
ably, rhodopsin was the most abundantly expressed GPCR and
among the most tissue specific, present at 350,000 arbitrary
units (a.u.) in eye but below 25 a.u. in other tissues (see below).
Because rhodopsin presumably serves no function in extraocu-
lar tissues, we adopted the convention that receptors with ex-
pression values below 25 a.u. in a given tissue were ‘‘absent.’’
With this criterion, only 25 GPCRs were expressed above back-
ground in all 41 tissues assayed (Table 1); 90 were expressed in
greater than half of tissues and 238 in less than half (Figure 1A).
Some ubiquitously expressed GPCRs were highly expressed in
blood vessels [i.e., Edg1(S1p1), F2r(Par1), Ednra, Ptger1],
perhaps accounting for their presence in all tissues (Table 1).
Other ubiquitously expressed receptors, including Gpr56,
Lec1(Lphn2), Lec2(Lphn1), Gpr107, Gpr108, Tm7sf1(Gpr137b),
Tm7sf1l1(Gpr137), Tm7sf3, and Tpra40(Gpr175), were ex-
pressed in five of five different nonvascular cell lines tested
and may indeed be expressed by most cell types in vivo (Table 1
and data not shown).
Save rhodopsin, nearly all GPCRs were expressed at levels
below 10,000 a.u. To provide an overview of GPCR distribution,
we designated receptors expressed at 25–250, 250–2500,
and >2500 a.u. as low, medium, and high expressors, respec-
tively, and we grouped tissues by system (e.g., central nervous
system [CNS], endocrine, cardiovascular, pulmonary, metabolic,
gastrointestinal, immune, reproductive, and cutaneous/barrier)
(Figure 1B). By these criteria, 15 or fewer receptors were ex-
pressed at high level in any tissue group but CNS.
As expected, receptors that were highly expressed in a given
tissue included receptors established to play an important role in
that tissue (Table 1). For example, light-detecting opsins were
highly expressed in eye, and dopamine, gamma-aminobutyric
acid (GABA), and glutamate receptors were highly expressed
in CNS (Table 1 and Figure 2A). In endocrine tissues, the extra-
cellular calcium-sensing receptor (Casr), which regulates para-562 Cell 135, 561–571, October 31, 2008 ª2008 Elsevier Inc.thyroid hormone secretion (Ho et al., 1995), was highly ex-
pressed in parathyroid/thyroid; the growth hormone-releasing
hormone receptor (Ghrhr), which regulates growth hormone se-
cretion (Lin et al., 1993), was high in pituitary; and the glucagon-
like peptide receptor 1 (Glp1r), which regulates insulin secretion
(Scrocchi et al., 1996), was high in islets (Table 1, Figure 2B, and
the Supplemental Data Set). The b3 adrenergic receptor (Adrb3)
and the niacin/ketone body receptor Hm74(Gpr109A) (Susulic
et al., 1995; Tunaru et al., 2003), which regulate lipolysis, were
among the most highly expressed receptors in adipose tissue
(Table 1 and see below). Glucagon receptor (Gcgr), an important
regulator of glucose homeostasis (Gelling et al., 2003), was
highly expressed in liver, and the parathyroid hormone receptor
(Pthr1), which regulates calcium and phosphate levels and
modulates the activity of 25-hydroxyvitamin D 1-hydroxylase
(Amizuka et al., 1997), was highly expressed in kidney (Table 1
and Figure 2C). In heart and blood vessels, angiotensin type 1a re-
ceptor (Agtr1), which regulates vascular tone (Ito et al., 1995; Su-
gaya et al., 1995), thrombin receptor (F2r; Par1) and sphingosine-
1-phosphate receptor (Edg1; S1p1), which play important roles in
vascular development (Connolly et al., 1996; Liu et al., 2000), and
the M2 muscarinic acetylcholine receptor (Chrm2), which regu-
lates heart rate (Gomeza et al., 1999) (Table 1 and Figure 2D),
were all highly expressed. Ccr9, Cxcr4, and Il8rb(Cxcr2), which
regulate leukocyte formation and function (Nagasawa et al.,
1996; Shuster et al., 1995; Wurbel et al., 2001), were abundant
in immune tissues (Table 1). Taken together, these results pro-
vided confidence that high-level expression in specific tissues
and tissue clusters correlates with physiological function and
might predict roles for less-well-characterized receptors.
Hierarchical Clustering of GPCR Expression
GPCR qPCR results were analyzed by unsupervised, hierarchical
clustering to further explore potential relationships between re-
ceptor expression and tissue function. The resulting dendograms
for both the tissue and receptor axes showed functional clusters
(Figure 3A for a thumbnail image and Figure S2 for a full-size
form). CNS tissues cerebellum, brainstem, hypothalamus, cere-
bral cortex, hippocampus, striatum, olfactory bulb, retina, and
whole eye clustered together, as did the immune/hematopoietic
tissues spleen, thymus, and bone marrow. The steroidogenic or-
gans adrenal gland and ovary clustered, but testes showed a very
distinct pattern of GPCR expression. Liver, kidney, and gall blad-
der formed a group, as did large intestine, small intestine, pan-
creas, and stomach. Skin, esophagus, and tongue also formed
a cluster, perhaps related to their common barrier function. Car-
Figure 1. Distribution of Mouse GPCR mRNA Expression In Vivo
(A) The number of GPCRs expressed in tissues presented in pie chart form.
Receptors expressed in all 41 tissues assayed are ‘‘ubiquitous’’; receptors
expressed in more than or less than half are ‘‘widespread’’ or ‘‘restricted,’’
respectively. A list of the ‘‘ubiquitous’’ receptors is included in Table 1.
(B) GPCR expression by tissue systems. High, medium, low, and absent are
defined in the Results. Tissue systems are defined as central nervous system
(CNS: cerebellum, brainstem, hypothalamus, cerebral cortex, hippocampus,
striatum, olfactory bulb, olfactory epithelium, retina, whole eye), endocrine
(pituitary gland, islets of Langerhans, adrenal gland, thyroid/parathyroid), car-
diovascular (aorta, vena cava, heart atrium, heart ventricle), pulmonary (lung,
trachea), metabolic (brown adipose tissue, white adipose tissue, isolated ad-
ipocytes, liver, skeletal muscle, kidney), gastroenteric (pancreas, gall bladder,
large intestine, small intestine, stomach, urinary bladder), reproductive (ovary,
testes, uterus), barrier (tongue, esophagus, skin), and immune (spleen, thy-
mus, bone marrow). A list of the highly expressed GPCRs in individual tissue
systems is included in Table 1.diac atrium and ventricle, skeletal muscle, aorta, and urinary
bladder formed a cluster, perhaps in part because of their sharing
a relative abundance of muscle cells. Brown adipose tissue
(BAT), white adipose tissue (WAT), isolated adipocytes, and
vena cava formed an ‘‘adipose’’ cluster. The presence of vena
cava in this cluster likely represents the incomplete removal of
surrounding fat from the samples.
A number of receptor axis clusters were easily recognized (Fig-
ure 3). A portion of the ‘‘immune/hematopoietic’’ cluster is shown
in Figure 3B. Included are Ccr9, Cxcr6, Cxcr4, Ccr3, Ccxcr1(Xcr1),
Blr1, Pgr16(Emr4), Gpr33, Ccr6, Gpr65(Tdag8), Cnr2, Edg6(S1p4),
Gpr9(Cxcr3), Ccr7, Fksg79(Gpr174), G2a(Gpr132), P2Y10,
Pgr27(Gpr114), Ebi2, Gpr18, and H963(Gpr171). Most of these
receptors are known to be expressed in and/or to play a role in im-
mune cells (Birkenbachetal., 1993; Forster etal., 1996, 1999; Hum-
bles et al., 2004; Karsak et al., 2007; Kim et al., 2001; Le et al., 2001;
Malone et al., 2004; Nagasawa et al., 1996; Rao et al., 1999; Soto
et al., 1998; Stacey et al., 2002; Varona et al., 2001; Wurbel et al.,
2001), but no role for Fksg79(Gpr174), Pgr27(Gpr114), and
H963(Gpr171) in this context has been described.
The pituitary cluster (Figure 3C) includes Bdkrb2, Gpr30(Gper),
Ghrhr, Gnrhr, Drd3, Mc3r, Sstr5, Gpr2(Ccr10), and Hcrtr1(Ox1r);
among these, Gpr2(Ccr10) has not been previously implicated in
pituitary gland function (Brailoiu et al., 2007; Date et al., 2000;
Kumar et al., 1997; Lin et al., 1993; Lorsignol et al., 1999; Tsut-
sumi et al., 1992).
The CNS cluster was by far the largest. Our analysis (Figure 1B
and Figure 3), as well as others (Vassilatis et al., 2003), suggests
that more than 80% of all nonodorant GPCRs are expressed in
CNS. In Figure 3D, we show a small portion of the CNS cluster
that includes Gpr101, Hcrtr2(Ox2r), Oprk1, Gpr83, Ntsr1, Gpr45,
Htr1a, Htr7, Oprm1, and Npy5r, all of which have been implicated
in regulation of neuronal function (Bates et al., 2006; Filliol et al.,
2000; Lovenberg et al., 1993; Marsh et al., 1998; Mazella et al.,
1996; Popova et al., 2007; Simonin et al., 1995; Willie et al., 2003).
Finally, Figure 3E shows the ‘‘eye/retina’’ cluster, which contains
Glp2r, Drd4, Grm6(Mglur6), Opn1mw, Opn1sw, Pgr5(Gpr152),
Rho, Rrh, Vlgr1(Gpr98), Oa1(Gpr143), and Rgr. Save Glp2r and
Pgr5(Gpr152), all are known to function in the eye (Chen et al.,
2001; Chiu et al., 1994; Cohen et al., 1992; Dryja et al., 2005; Incerti
et al., 2000; McGee et al., 2006; Nathans and Hogness, 1983; Sun
et al., 1997a, 1997b).
Taken together, the results outlined above reveal that tissues
cluster into largely expected functional groups purely on the basis
of their GPCR repertoires, and both expected and unique groups
of receptors cluster by tissue function. These data identify sets of
receptors involved in specific aspects of physiology and should
prove useful in providing clues regarding in vivo roles for orphan
GPCRs and new roles for receptors with known ligands. To test
the latter prediction, we sought a possible role for a recently
deorphanized receptor, Gpr91, found in the adipose cluster.
Extracellular Succinate Inhibits Lipolysis,
Likely via Gpr91
Thirteen GPCRs defined an adipose cluster (Figure 4A and cir-
cled area in Figure 3A): Gpr64(He6), Hm74(Gpr109a), Adrb3,
Gpr81, Pgr4(Gpr120), Gpr23(Lpa4), Tshr, Opn3, Oxtr, Sctr,
Gpr91(Suncr1), Pthr1, and Ptger3(Ep3). Ligands for most ofCell 135, 561–571, October 31, 2008 ª2008 Elsevier Inc. 563
these receptors are known to affect adipocyte function (Butcher
and Carlson, 1970; Gotoh et al., 2007; Moskowitz and Fain,
1969; Rodbell, 1964; Sinha et al., 1976; Susulic et al., 1995; Tunaru
et al., 2003; Valet et al., 1998), but, to our knowledge, no role for
Gpr64(He6), Gpr81, Opn3, or Gpr91(Suncr1) in adipose tissue
has been reported. He et al. demonstrated that the citric acid cycle
Figure 2. qRT-PCR Tissue Distribution Yields Predicted Patterns of Expression
Representative GPCRs that were highly expressed in distinct tissue systems were selected from Figure 1B and Table 1 to illustrate tissue specificity, range of
expression levels, and reproducibility. Examples are shown for the following: CNS: metabotropic glutamate receptor 1 [Grm1(Mglur1)] and rhodopsin [Rho] (A);
endocrine system: growth hormone releasing hormone receptor [Ghrhr] and the extracellular calcium-sensing receptor [Casr] (B); metabolic tissues: parathyroid
hormone receptor 1 [Pthr1] and glucagon receptor [Gcgr] (C); and cardiovascular system: M2 muscarinic receptor [Chrm2] and the sphingosine-1-phosphate
receptor 1 [Edg1(S1p1)] (D). Values are plotted as the mean ± SEM; n = 2–5.
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intermediate succinate can activate Gpr91 and that Gpr91, pre-
sumably in kidney, mediates elevation of plasma renin levels and
blood pressure in response to exogenous succinate (He et al.,
2004). Like Adrb3 and Hm74(Gpr109a), Gpr91(Suncr1) mRNA
was most highly expressed in white adipose tissue (WAT) and
was abundant in purified adipocytes (Figure 4B). Gpr91 is at least
partially Gi coupled (He et al., 2004), and Gi-coupled GPCRs are
known to inhibit lipolysis in adipose tissues (Moreno et al., 1983).
Accordingly, we examined the effect of succinate on isoprotere-
nol-induced lipolysis in isolated WAT (Isoproterenol has relatively
low affinity for Adrb3 and most likely acts via Adrb2 in this context).
Succinate inhibited lipolysis in a dose-dependent manner with
an apparent IC50 of 44 mM (Figure 4C), a concentration similar to
the EC50 for succinate activation of Gpr91 heterologously ex-
pressed in 293 cells (He et al., 2004). Inhibition of lipolysis by
succinate was ablated by pertussis toxin pretreatment. 3T3-L1
adipocyte-like cells, which do not express Gpr91 mRNA (J.B.R.
Figure 3. Unsupervised Hierarchical Clus-
tering of GPCR Expression across Tissues
(A) Transformed qRT-PCR data for the 353 GPCRs
assayed in the 41 tissues was evaluated by unsu-
pervised hierarchical clustering with average
linkage with Cluster 3.0 and visualized with Java
TreeView (see the Experimental Procedures). A
thumbnail image is shown here; a full-size version
is shown in Figure S2. Multiple clusters and
subclusters were seen, and five were chosen for
further analysis. The fifth cluster (blue circle to-
ward the bottom) is discussed in Figure 4.
(B) A portion of the ‘‘immune/hematopoietic’’ clus-
ter is shown; note the abundance of chemokine
receptors.
(C) The ‘‘pituitary’’ cluster contains many well-
documented regulators of pituitary function,
including Ghrhr and Gnrhr.
(D) A small portion of the ‘‘CNS’’ cluster, by far the
largest. This portion contains receptors for impor-
tant neurotransmitters including serotonin, neuro-
peptide Y, orexin and opiates.
(E) The ‘‘eye/retinal’’ cluster contains light-sensing
opsins as well as other receptors known to regu-
late vision.
and S.R.C., unpublished data) and were
not sensitive to the antilipolytic effects
of succinate, became succinate sensi-
tive when transfected with a mammalian
expression vector for GPR91 (Figure 4E).
These data strongly suggest that succi-
nate inhibits lipolysis in WAT via a
Gi-coupled GPCR, presumably Gpr91.
Pairwise Analysis of GPCR
Coexpression May Help Identify
Multiple Roles for Individual GPCRs
To explore whether coexpression of
GPCRs might provide additional clues
to function, we compared the expression
pattern of each GPCR to that of every
other to generate the map shown in Figure 5. Positive and neg-
ative correlation of expression patterns are indicated by yellow
and blue colors, respectively (Figure 5A and Figure S3). Such
correlation maps are a powerful tool for organizing and analyzing
gene-gene and protein-protein interactions on a global scale
(Collins et al., 2007a, 2007b; Krogan et al., 2006; Schuldiner
et al., 2005; Segre et al., 2005).
Not surprisingly, tissue-specific receptor clusters similar to
those seen in Figure 3 were, for the most part, recapitulated as
distinct blocks along the diagonal. Examples are shown in Fig-
ures 5B, 5C, and 5D which largely reproduce the immune/hema-
topoietic, eye/retina, and adipose clusters of Figures 3B, 3E, and
4A, respectively. Off-diagonal blocks drew attention to possible
roles for receptors in other contexts. By pointing out possible
roles for receptors outside of their main physiological cluster,
such analysis may be useful in understanding and predicting
on-target drug side effects (see the Discussion).
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Figure 4. Gpr91(Sucnr1) and Its Ligand, Succinate, can Inhibit Lipolysis in Adipocytes
(A) The ‘‘adipose’’ cluster (blue circle, lower part Figure 3A) contained numerous regulators of adipocyte function.
(B) Adrb3, Hm74(Gpr109a) and Gpr91(Sucnr1) were expressed at similarly high levels in white adipose tissues (WAT) and isolated adipocytes.
(C) Isolated WAT was treated with isoproterenol (20 nM) to stimulate lipolysis, as measured by glycerol release at 3 hr. Succinate added concurrently with
isoproterenol inhibited lipolysis in a concentration-dependent manner with an apparent IC50 of approximately 44 mM.
(D) Isolated WAT was pretreated either with KRH/BSA or KRH/BSA containing pertussis toxin (PTX; 100 ng/mL) for 3 hr prior to exposure to the indicated con-
ditions. Isoproterenol (20 nM) -stimulated glycerol release was inhibited by the addition of 80 mM succinate. Pretreatment of WAT with PTX abrogated this effect,
suggesting succinate’s inhibition of lipolysis occurred in a Gi/o-dependent manner, consistent with Gpr91 activation.
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DISCUSSION
We have quantitated mRNA levels for the nonodorant G protein-
coupled receptors encoded in the mouse genome in 41 tissues
and provide this data set as a resource for predicting roles for
incompletely characterized GPCRs, exploring tissue-specific
gene expression, and other purposes. The fact that tissues that
comprise classical physiological systems (cardiovascular, gas-
trointestinal, etc.) were clustered together simply on the basis
of their GPCR repertoires speaks to the key roles that GPCRs
play in homeostatic regulation.
Our anatomic expression profiling yielded a large amount of in-
formation consistent with known physiology, and high-level ex-
pression of a GPCR in a particular tissue cluster or specific tissue
correlated well with its physiological role. Although this result is
not surprising, it does provide confidence that roles for orphan
receptors or GPCRs not known to play a role in a particular phys-
iological process might be predicted by presence in a given clus-
ter. Our demonstration that Gpr91 expression pointed to a role
for extracellular succinate in regulating lipolysis in adipocytes
validates this notion and is also of intrinsic interest.
The concentration of succinate in plasma has been reported at
5–125 mM, a range that surrounds the EC50 for Gpr91 activation
(He et al., 2004) and the IC50 for inhibition of lipolysis in WAT (Fig-
ure 4). Succinate concentrations increase during exercise and
metabolic acidosis and, in rodents, in hyperglycemic metabolic
states (Forni et al., 2005; Hochachka and Dressendorfer, 1976;
Krebs, 1950; Kushnir et al., 2001; Nordmann and Nordmann,
1961; Sadagopan et al., 2007). Thus, excursions in the levels of
extracellular succinate do occur and might regulate adipocyte
function in vivo. Adipocyte function was not investigated in
mice lacking Gpr91, which are grossly healthy (He et al., 2004).
Overall, a physiological role for succinate in regulating adipocyte
metabolism is plausible, but when and how such a system might
be important and/or redundant with other systems that govern
adipocyte function remains unknown.
Forty-nine of the 353 GPCRs profiled were expressed in only
one or two of the 41 tissues examined (see Table S1). Such con-
fined expression might point out targets of pharmaceutical inter-
est. For example, testes showed a GPCR expression pattern
very distinct from that of other tissues. Gpr150, Gpr66, Gpr15,
Mtnr1a, and Pgr23 were almost perfectly specific to testes.
Whether such receptors play a role in spermatogenesis or other
testicular functions and their potential utility as targets for drugs
aimed at controlling fertility is unknown.
A comparison of each receptor’s expression pattern with that
of every other (Figure 5) provided a means of pointing out possible
roles for a given receptor outside its main physiological cluster.
(E) Differentiated 3T3-L1 cells, which do not express Gpr91 mRNA, were transfected with mammalian expression vectors containing b2 adrenergic receptor
(Adrb2) and control (green fluorescent protein; GFP) or Adrb2 and GPR91. Succinate (100 mM) inhibited isoproterenol (10 nM) -induced lipolysis in cells cotrans-
fected with GPR91 but not GFP. The data shown are mean ± SD, n = 3; p = 0.025, unpaired student’s t test. This experiment was done three times with similar
results.
Figure 5. Hierarchical-Cluster Analysis of
Pairwise GPCR Expression Reveals Addi-
tional Levels of Interaction
(A) Pearson correlation r coefficients were calcu-
lated for interactions between each GPCR with
all others on the basis of tissue expression pat-
terns. The resulting data set was further analyzed
with Cluster 3.0 with complete linkage and visual-
ized with TreeView. A thumbnail image is shown
here, and a full-size image is available in Fig-
ure S3. Receptors with similar distributions are
shown in yellow; distinct distributions are shown
in blue. The x and y axes are mirror images of
one another. The diagonal represents each
receptor interacting with itself (perfect similarity
in distribution).
(B–D) Clustering of receptors by similarity of
expression reveals an immune/hematopoietic
grouping very similar to that in Figure 3B (B), an
eye/retinal cluster similar to that in Figure 3E
(C), and an adipose cluster similar to that in
Figure 4A (D). However, analysis of GPCR inter-
action clusters off the diagonal suggested recep-
tor functions outside of their most obvious phys-
iological roles. This might aid in understanding
and prediction of on-target drug side effects
(see the Discussion and Figure S1).
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Hm74(Gpr109a), the ketone body receptor that is activated ther-
apeutically by niacin to treat dyslipidemias (Soga et al., 2003; Tu-
naru et al., 2003; Wise et al., 2003), provides an interesting exam-
ple. By traditional clustering analysis, Hm74(Gpr109a) is placed
in the ‘‘adipose’’ cluster (Figure 4A), and activation of adipocyte
Hm74 likely mediates the antilipolytic actions of niacin (Tunaru
et al., 2003). It was recently shown that the skin-flushing side ef-
fect of niacin (Carlson, 2005) is mediated by Hm74 expression by
bone-marrow-derived epidermal Langerhans cells that release of
vasodilatory prostanoids (Benyo et al., 2006; Benyo et al., 2005).
By quantitative profiling across tissues, Hm74 was noted to be
expressed relatively highly in skin and other ‘‘barrier-cluster’’ tis-
sues as well as adipose (Figure 4B). By expression correlation
analysis, Hm74 was not found with the adipose cluster on the
diagonal but instead clustered with receptors with more wide-
spread expression (Figures S1 and S3). A search of off-diagonal
interactions revealed that Hm74 interacts not only with the adi-
pose cluster but also with receptors in both immune and barrier
clusters (Figure S1 and S3). Thus, analysis of GPCR expression
data from these different perspectives may generate hypotheses
regarding on-target side effects of drugs.
GPCR genes are usually relatively small, often intronless, and
range from closely to distantly related. These features, plus the
availability of quantitative expression data across multiple tis-
sues for hundreds of related genes that show clusters based
on shared tissue-specific patterns, may provide a resource for
those interested in identifying the combinations of cis-acting
elements that specify gene expression in a given cell type.
Some GPCRs are thought to function as heterodimers, and
cluster analysis for coexpression might point to potential recep-
tor pairs. For example, Gabbr1 is currently thought to function as
an obligate heterodimer with Gpr51(Gabbr2) (Jones et al., 1998;
Kaupmann et al., 1998; Kuner et al., 1999; White et al., 1998). Our
data (Supplemental Data Set) and those of others (Calver et al.,
2000) demonstrate similar expression patterns for these recep-
tors in CNS and divergent expression in the periphery. These re-
sults are consistent with Gabbr1 and Gabbr2 heterodimer forma-
tion in the CNS but raise the possibility that in the periphery,
expression of one or the other partner is regulated, that these re-
ceptors may use other partners, and/or that heterodimerization
may not be required in all settings (Cheng et al., 2007).
Several caveats should be stated regarding interpreting our
expression data. (1) Relative mRNA levels, of course, will not
always reflect relative protein expression levels or the relative
importance of a particular receptor in a particular tissue. Indeed,
some important receptors such as adrenergic receptors were
expressed at relatively low levels. (2) Tissues are comprised of
multiple cell types, and receptor expression can be restricted
to a minority cell type. In the extreme, receptor expression in
a minority population can be missed by whole-tissue analysis.
For example, neither our qPCR data (Supplemental Data Set)
nor those of others (Liberles and Buck, 2006) detected trace
amine associated receptor 1 (Taar1) expression in brain, but
a Taar 1 Lac-Z knockin mouse revealed Taar1 expression in dis-
crete neuronal populations and Taar1-dependent regulation of
dopaminergic activity (Lindemann et al., 2008). (3) The presence
of a receptor within a particular anatomical cluster does not
exclude important functions in tissues outside that cluster. For568 Cell 135, 561–571, October 31, 2008 ª2008 Elsevier Inc.example, the D2 dopamine receptor (Drd2) is recognized as
the major dopamine receptor subtype in pituitary (Kelly et al.,
1997; Saiardi et al., 1997), but Drd2 was in the CNS cluster,
whereas the D3 dopamine receptor (Drd3) was in the pituitary
cluster (Figure 3C). The cluster analysis presented here used
the Pearson correlation, which normalizes expression levels
(see the Experimental Procedures) to focus on gaining informa-
tion from the pattern of gene expression at the cost of ignoring
absolute levels of receptor expression, and the Drd cluster re-
sults are presumably a result of the fact that Drd2 is expressed
at moderate levels in numerous CNS structures whereas Drd3
is expressed at very low levels in only a few structures (Supple-
mental Data Set). However, our quantitative expression data
(Supplemental Data Set) reveal that Drd2 is expressed approxi-
mately 100-fold higher than Drd3 in pituitary, consistent with the
dominant role of Drd2 in pituitary function. Thus, this resource is
best utilized when the data are analyzed from several perspec-
tives and should be viewed as a means of generating hypotheses
to be tested experimentally. Raw expression data for the 353
GPCRs in the 41 organ samples are available at http://pdsp.
med.unc.edu/apGPCRe/, for those who wish to perform their
own analyses.
Lastly, expression of individual GPCRs in specific tissues can
be different in human and mouse. When used together with
GPCR expression patterns in human (SymAtlas, SAGEmap),
our data set should facilitate rational use of mouse to model
the roles of GPCRs in human physiology and disease.
EXPERIMENTAL PROCEDURES
qRT-PCR
Ten-week-old C56BL/6 mice (Jackson Labs) were housed in University of
California, San Francisco (UCSF) animal facilities for 2 weeks prior to organ
harvest. Mice were anesthetized with ketamine/xylazine and transcardially-
perfused with saline for the removal of blood. Organs were dissected, rapidly
frozen in liquid nitrogen, and stored at 80C until the time of RNA isolation.
Corresponding organs from two male and two female mice were pooled to
yield a single tissue RNA sample (i.e., for each separate replicate, organs of
four mice were pooled), with the exception of sex-specific organs, which
were pooled from two mice. Pancreas was removed and stored for 24 hr in
RNAlater at 4C prior to storage at 80C. Islets of Langerhans were isolated
from 20 male C57BL/6 males by the UCSF islet isolation core. Primary adipo-
cytes were isolated from sex organ fat pads as described (Rodbell, 1964). Tis-
sues were first homogenized, and crude RNA was extracted with Trizol (Invitro-
gen). RNA was further purified with RNeasy columns (QIAGEN) with on-column
DNase I digestion. RNA samples were treated with DNase I a second time and
concentrated with the Zymo Research DNA-free RNA kit. First-strand synthe-
sis was performed with the iScript kit (Biorad). qPCR assays were performed in
a 384-well format with an ABI7900HT, Platinum qPCR mix (Invitrogen) and
10 ml reactions. Cycle threshold (Ct) values were collected at 0.2 for all sam-
ples; Ct values for individual GPCRs were compared to Ct values for four inter-
nal controls (b-actin, cyclophilin, GAPDH, and ribosomal protein S9) for all tis-
sues. Taqman primer/probes have been described (Regard et al., 2007), and
sequences are available in Table S3. There were 22 mouse GPCRs for which
we were unable to generate primer/probe sets that produced a signal above
background in any tissue. A lack of data should be viewed as ‘‘no data’’ for
these receptors, which are listed in Table S2. PCR efficiencies were calculated
as described (Peirson et al., 2003). 2(CtGPCR  Ctcontrol) multiplied by 215 was
used for graphical representation of qPCR data. Repeated qPCR analysis of
a given tissue RNA sample, i.e., technical replicates, yielded variations of
less than 10%. Two to five independently prepared RNA samples from sepa-
rate tissue isolations were analyzed for assessment of in vivo expression
variability, which was also generally less than 10%. Data presented in the
Supplemental Data Set and elsewhere represent the mean ± SEM (n = 2–5).
Lipolysis
C57BL6 mice were euthanized by cervical dislocation. Sex organ fat pads were
dissected and finely minced and washed four times with Krebs-Ringer HEPES
buffer containing 4% fatty-acid-free bovine serum albumin (BSA), 5 mM glu-
cose, and 0.1 mM ascorbic acid (KRH-BSA). Twenty-five to 30 milligrams of
WAT mincate was placed in the upper well of transwells in a 24-well plate
and placed in a tissue culture incubator at 37C with the specified cocktail
for the indicated amount of time. KRH-BSA samples were taken from the wells
at the specified time for quantification of glycerol release and were divided by
the weight of the mincate. Pertussis toxin (Calbiochem) pretreatment was per-
formed for 4 hr in a tissue culture incubator with mild shaking. 3T3-L1 cells
(ATCC) were cultured and differentiated via standard protocols. Fully differen-
tiated 3T3-L1 cells were transfected (Amaxa, Nucleofection) with mammalian
expression vectors containing b2-adrenergic receptor (Adrb2—generously
provided by Dr. J. Silvio Gutkind) and GPR91 (Missouri S&T) and allowed to
recover for 48–72 hr prior to lipolysis assays. Free glycerol was quantified
with the Free Glycerol reagent (Sigma). IC50 for succinate inhibition of isopro-
terenol-induced lipolysis was calculated with Prism4.
Hierarchical Clustering
All analysis of the data was performed with Python, Scipy, and Excel. For pair-
wise correlation in Figure 5, Pearson correlation r values were computed
between the expression vectors of every pair of genes in the data set. Trans-
formed data were hierarchically clustered with Cluster 3.0 (Eisen et al., 1998)
and visualized with Java TreeView (Saldanha, 2004).
SUPPLEMENTAL DATA
Supplemental Data include three figures, three tables, and one data set and
can be found with this article online at http://www.cell.com/supplemental/
S0092-8674(08)01129-X.
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